Current health screening solutions generally include questioner-based risk assessment tools and blood tests. Risk assessment tools are population-based and week indicators of measuring risk. Blood tests do not identify early indications of someone developing chronic conditions like Type 2 Diabetes, Hypertension and Dyslipidemia and are painful. Due to these reasons, the patient is not having an oppotunity to prevent developing these conditions, causing delayed care and incresed cost of healthcare.
Aarca Research solutions encourage patients to undergo regular health screenings. We have developed a first-of-its-kind technology using artificial intelligence for early detection of Type 2 diabetes, Hypertension and Dyslipidemia. Our technology takes input from an FDA-cleared thermal camera and uses computer vision and machine learning models to identify the early indicators of the user, and provides the report in real-time. Now an individual has a chance to take precautions and modify lifestyle to delay or avoid the onset of these conditions.
We are a multi-disciplinary team, from medicine, biomedical engineering, electrical engineering, and software engineering backgrounds with more than thirty years of healthcare and entrepreneurship experience. We bring innovation, and agility together.
If you are interested or currently providing health & wellness services, provide us with your details, and we will contact you.